M K Proteins Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Mar'26

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Quarterly Analysis Highlights - YoY

Net Sales

YoY Growth in quarter ended Mar 2026 is 6.37% vs 57.94% in Mar 2025

Standalone Net Profit

YoY Growth in quarter ended Mar 2026 is -59.29% vs -51.97% in Mar 2025

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Mar 2026 is -46.35% vs -44.66% in Mar 2025

Interest

YoY Growth in quarter ended Mar 2026 is 17.91% vs 67.50% in Mar 2025

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025

Compare Quarterly Results Of M K Proteins With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

145.94

336.92

-190.98

-56.68%

Other Operating Income

0.00

Total Operating income

145.94

336.92

-190.98

-56.68%

Raw Material Cost

96.51

259.89

-163.38

-62.87%

Purchase of Finished goods

19.92

56.70

-36.78

-64.87%

(Increase) / Decrease In Stocks

16.76

2.09

14.67

701.91%

Employee Cost

1.11

2.21

-1.10

-49.77%

Power Cost

0.00

5.62

-5.62

-100.00%

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

2.03

-2.03

-100.00%

Other Expenses

9.14

7.35

1.79

24.35%

Total Expenditure (Excl Depreciation)

143.44

335.89

-192.45

-57.30%

Operating Profit (PBDIT) excl Other Income

2.50

1.03

1.47

142.72%

Other Income

0.12

0.00

Operating Profit (PBDIT)

2.62

1.15

1.47

127.83%

Interest

0.79

1.29

-0.50

-38.76%

Exceptional Items

0.00

Gross Profit (PBDT)

1.83

-0.14

1.97

1,407.14%

Depreciation

0.11

0.85

-0.74

-87.06%

Profit Before Tax

1.72

-1.00

2.72

272.00%

Tax

0.58

0.19

0.39

205.26%

Provisions and contingencies

0.00

Profit After Tax

1.14

-1.19

2.33

195.80%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

1.14

-1.19

2.33

195.80%

Equity Capital

37.54

16.10

21.44

133.17%

Face Value

1.00

2.00

0.00

Reserves

38.76

0.00

38.76

Earnings per share (EPS)

0.03

-0.15

0.18

120.00%

Diluted Earnings per share

0.03

-0.15

0.18

120.00%

Operating Profit Margin (Excl OI)

1.71%

0.31%

0.00

1.40%

Gross Profit Margin

1.25%

-0.04%

0.00

1.29%

PAT Margin

0.78%

-0.35%

0.00

1.13%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 145.94 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is 62.95% vs 176.16% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 6.37% vs 57.94% in Mar 2025

Quarterly - Standalone Net Profit

Standalone Net Profit 1.14 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is -20.28% vs 90.67% in Dec 2025

YoY Growth in quarter ended Mar 2026 is -59.29% vs -51.97% in Mar 2025

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 2.50 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is 5.49% vs 125.71% in Dec 2025

YoY Growth in quarter ended Mar 2026 is -46.35% vs -44.66% in Mar 2025

Quarterly - Interest

Interest 0.79 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is 163.33% vs 400.00% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 17.91% vs 67.50% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 1.71%

in Mar 2026

Figures in %

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025